'Remission rates for patients with some forms of blood cancers treated with CAR T-cell therapy can exceed 80 per cent. But it is certainly not a miracle treatment for all forms of cancer. Biology is messy, the quality of cell therapies variable and the treatment does not work on all patients. And, despite its life-saving promise, cell therapy suffers one additional serious drawback: its cost. Emily’s cell therapy cost $473,000, putting it beyond the reach of all but the richest or best-insured. Thousands of patients who could be cured of various diseases are dying because of supply constraints. “Science is outstripping our ability to manufacture,” says June.'
#Immunology #Immunotherapy #CARTcell
https://www.ft.com/content/626007c4-9127-4682-9dab-154b32434029